Cote I, Jacobs P, Cumming DC. Use of health services associated with increased menstrual loss in the United States. Am J Obstet Gynecol. 2003;188(2):343-8. doi: 10.1067/mob.2003.92. [PubMed: 12592237].

Santer M, Warner P, Wyke S. A Scottish postal survey suggested that the prevailing clinical preoccupation with heavy periods does not reflect the epidemiology of reported symptoms and problems. J Clin Epidemiol. 2005;58(11):1206-10. doi: 10.1016/j.jclinepi.2005.02.026. [PubMed: 16223665].

Shapley M, Jordan K, Croft PR. An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract. 2004;54(502):359-63. [PubMed: 15113519].

Goldstein SR, Lumsden MA. Abnormal uterine bleeding in perimenopause. Climacteric. 2017;20(20):414-20. doi: 10.1080/13697137.2017.1358921. [PubMed: 28780893].

Nicula R, Diculescu D, Lencu CC, Ciortea R, Bucuri CE, Oltean IA, et al. Accuracy of transvaginal ultrasonography compared to endometrial biopsy for the etiological diagnosis of abnormal perimenopausal bleeding. Clujul Med. 2017;90(1):33-9. doi: 10.15386/cjmed-670. [PubMed: 28246495].

Saccardi C, Vitagliano A, Marchetti M, Lo Turco A, Tosatto S, Palumbo M, et al. Endometrial cancer risk prediction according to indication of diagnostic hysteroscopy in post-menopausal women. Diagnostics. 2020;10(5):257. doi: 10.3390/diagnostics10050257. [PubMed: 32349386].

Espindola D, Kennedy KA, Fischer EG. Management of abnormal uterine bleeding and the pathology of endometrial hyperplasia. Obstet Gynecol Clin North Am. 2007;34(4):717-37. doi: 10.1016/j.ogc.2007.09.001. [PubMed: 18061866].

Early detection, diagnosis and staging of endometrial cancer. 2020. Available from:

https://www.cancer.org/cancer/endometrial-cancer/detection-diagnosis-staging/signs and-symptoms.html.

Munro MG, Critchley HO, Broder MS, Fraser IS, Disorders FWGoM. FIGO classification system (PALMCOEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3-13. doi: 10.1016/j.ijgo.2010.11.011. [PubMed: 21345435].

Timmermans A, Opmeer BC, Khan KS, Bachmann LM, Epstein E, Clark TJ, et al. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynecol. 2010;116(1):160-7. doi: 10.1097/AOG.0b013e3181e3e7e8. [PubMed: 20567183].

Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand. 2002;81(9):799-816. doi: 10.1034/j.1600-0412.2001.810902.x. [PubMed: 12225294].

Getpook C, Wattanakumtornkul S. Endometrial thickness screening in premenopausal women with abnormal uterine bleeding. J Obstet Gynaecol Res. 2006;32(6):588-92.

Park YR, Lee SW, Kim Y, Bae IY, Kim HK, Choe J, et al. Endometrial thickness cut-off value by transvaginal ultrasonography for screening of endometrial pathology in premenopausal and postmenopausal women. Obstet Gynecol Sci. 2019;62(6):445-53. doi: 10.5468/ogs.2019.62.6.445. [PubMed: 31777741].

Siegal R, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7-33. doi: 10.3322/caac.21654. [PubMed: 33433946].

Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ, et al. Concurrent endometrial carcinoma in women with biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106(4):812-9. doi: 10.1002/cncr.21650. [PubMed: 16400639].

Kadirogullari P, Atalay CR, Ozdemir O, Sari ME. Prevalence of Co-existing Endometrial Carcinoma in Patients with Preoperative Diagnosis of Endometrial Hyperplasia. J Clin Diagn Res. 2015;9(10):10-4. doi: 10.7860/JCDR/2015/12484.6618. [PubMed: 26557570].

Gunes, G. (2009). Malatya İl Merkezindeki 35 Yaş ve Üzeri Kadınlarda Menopoz ve İlişkili Faktörlerin Belirlenmesi. Medical Sciences 4 (3), 59-66.

Iram S, Musonda P, Ewies AA: Premenopausal bleeding: when should the endometrium be investigated? – A retrospective non-comparative study of 3,006 women. Eur J Obstet Gynecol Reprod Biol. 2010;148(1):86–9. doi: 10.1016/j.ejogrb.2009.09.023. [PubMed: 19853362].

Esmer AC, Akbayir O, Goksedef BP, Gunduz N, Kisacık S, Dagdeviren H, et al. Is there an appropriate cutoff age for sampling the endometrium in premenopausal bleeding? Gynecol Obstet Invest. 2014;77(1):40-4. doi: 10.1159/000356959. [PubMed: 24334971].

Doraiswami S, Johnson T, Rao S, Rajkumar A, Vijayaraghavan J, Panicker VK. Study of endometrial pathology in abnormal uterine bleeding. J Obstet Gynecol India. 2011;61(4):426-30. doi: 10.1007/s13224-011-0047-2. [PubMed: 22851826].

ACOG . diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012;120(1):197-206. doi: 10.1097/AOG.0b013e318262e320. [PubMed: 22914421].

Vilos G, Lefebvre G, Graves G. Guidelines for the management of abnormal uterine bleeding. J Obstet Gynaecol Can. 2001;23(8):704–9.

Tosun AK, Tosun I, Suer N, Güzin K. Preoperatif benign endike olgularda endometriyal örneklemenin gerekliliği. Abant Med J. 2014; 3 :156-60. https://doi.org/10.5505/abantmedj.2014.87004.

Inal ZO, Inal HA, Kucukosmanoglu I, Kucukkendirci H. Assessment of endometrial sampling and histopathological results: Analysis of 4,247 cases. Eurasian J Med. 2017;49(1):44-7. doi: 10.5152/eurasianjmed.2017.16269. [PubMed: 28416932].

Azatçam M, Altun E, Usta A. Histopathological evaluation of endometrial sampling in different age groups -1374 cases. Medeniyet Med J. 2017;32(1):26-32. doi: 10.5222/MMJ.2017.026.

Yasmin F, Farrukh R, Kamal F. Efficacy of pipelle as a tool for endometrial biopsy. Biomedica. 2007;23:12–5.

Saadia A, Mubarik A, Zubair A, Jamal S, Zafar A. Diagnostic accuracy of endometrial curettage in endometrial pathology. J Ayub Med Coll Abbottabad. 2011;23(1):129–31. [PubMed: 22830167].

Dijkhuizen FPH, Mol BW, Brolmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer. 2000;89(8):1765–72. [PubMed: 11042572].

Turan G, Bahat PY, Çetin BA, Selçuki NFT. How Compatible are Hysterectomy Pathology Results with Endometrial Biopsy in Abnormal Uterine Bleeding Women? Kafkas J Med Sci. 2020;10(2):104–9 doi: 10.5505/kjms.2020.80148.

Sargın MA, Yassa M, Somay A, Ergun E, Orhan E, Tuğ N. Clinical outcomes of postmenopausal patients with insufficient sample from endometrial biopsy. Bosphorus Med J. 2016;3(2):54-59

Çakır A. Öz İ, Ün B. (2020). Endometrı̇ al Örnekleme Sonuçlarımız: 365 Olgunun Analizi. Bozok Tıp Dergisi. 10.16919/bozoktip.539875.

Constantine GD, Kessler G, Graham S, Goldstein SR. Increased incidence of endometrial cancer following the women’s health initiative: an assessment of risk factors. J Womens Health (Larchmt). 2019;28(2):237–43. doi: 10.1089/jwh.2018.6956. [PubMed: 30484734].

Cote ML, Ruterbusch JJ, Olson SH, Lu K, Ali-Fehmi R. The growing burden of endometrial cancer: a major racial disparity affecting black women. Cancer Epidemiol Biomarkers Prev. 2015;24(9):1407–15. doi: 10.1158/1055-9965.EPI-15-0316. [PubMed: 26290568].

Riera R, Bagattini ÂM, Pacheco RL, Pachito DV, Roitberg F, Ilbawi A. Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review. JCO Glob Oncol. 2021;7(1):311-23. doi: 10.1200/GO.20.00639. [PubMed: 33617304].

Lai AG, Pasea L, Banerjee A, Denaxas S, Katsoulis M, Chang WH, et al. Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency. BMJ Open. 2020;10:e043828. doi: 10.1101/2020.05.27.20083287.